TIDMAPH

RNS Number : 3812O

Alliance Pharma PLC

27 May 2015

 
 For immediate release                                                    27 May 2015

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 27(th) May 2015 it awarded the following options over ordinary shares of the Company to certain Directors.

 
 Name            Position     Number      Exercise     Date of    Percentage 
                               of Share    price        vesting    of issued 
                               Options     per Share               ordinary 
                               Awarded                             share 
                                                                   capital 
--------------  -----------  ----------  -----------  ---------  ----------- 
 Anthony         Executive 
  Booley          Director    146,003     43.75        May 2018   0.055 
--------------  -----------  ----------  -----------  ---------  ----------- 
 Peter           Executive 
  Butterfield     Director    155,000     43.75        May 2018   0.059 
--------------  -----------  ----------  -----------  ---------  -----------

For further information:

 
 Alliance Pharma plc                  + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
 Sarah Robinson, Company Secretary 
 www.alliancepharma.co.uk 
                                          + 44 (0) 20 7466 
 Buchanan                                             5000 
 Mark Court / Sophie Cowles 
  / Jane Glover 
 
                                          + 44 (0) 20 7260 
 Numis Securities Limited                             1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: David 
  Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSPKODPBBKDKPB

Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alliance Pharma Charts.
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alliance Pharma Charts.